Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma
March 05, 2026
March 05, 2026
BIRMINGHAM, Alabama, March 5 -- The University of Alabama issued the following news:
* * *
Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma
*
Luciano Costa, M.D., Ph.D., led the MajesTEC-3 clinical trial, which shows that using a new two-drug immunotherapy regimen can lead to long-lasting remission for patients with multiple myeloma. (Photography: Ian Logue) A researcher at the U . . .
* * *
Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma
*
Luciano Costa, M.D., Ph.D., led the MajesTEC-3 clinical trial, which shows that using a new two-drug immunotherapy regimen can lead to long-lasting remission for patients with multiple myeloma. (Photography: Ian Logue) A researcher at the U . . .
